Showing results (341-350 of 358) with videos related to

Sort By:
Pageof 36
British Journal of Cancer|March 9, 2018
Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancerN O Elander, K Aughton, P Ghaneh, et al.
Surgery|May 27, 2014
Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)Maximilian Bockhorn, Faik G Uzunoglu, Mustapha Adham, et al.
British Journal of Cancer|March 11, 2018
Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapyN O Elander, K Aughton, P Ghaneh, et al.
Science (New York, N.Y.)|October 24, 2024
Detection of interstellar 1-cyanopyrene: A four-ring polycyclic aromatic hydrocarbonGabi Wenzel, Ilsa R Cooke, P Bryan Changala, et al.
Surgery|December 29, 2016
Pancreatic anastomosis after pancreatoduodenectomy: A position statement by the International Study Group of Pancreatic Surgery (ISGPS)Shailesh V Shrikhande, Masillamany Sivasanker, Charles M Vollmer, et al.
Surgery|October 4, 2016
Definition and classification of chyle leak after pancreatic operation: A consensus statement by the International Study Group on Pancreatic SurgeryMarc G Besselink, L Bengt van Rijssen, Claudio Bassi, et al.
Pancreas|July 12, 2017
Describing Peripancreatic Collections According to the Revised Atlanta Classification of Acute Pancreatitis: An International Interobserver Agreement StudyStefan A Bouwense, Sandra van Brunschot, Hjalmar C van Santvoort, et al.
Journal of the National Cancer Institute|December 5, 2013
Pancreatic cancer hENT1 expression and survival from gemcitabine in patients from the ESPAC-3 trialWilliam Greenhalf, Paula Ghaneh, John P Neoptolemos, et al.
Surgery|July 22, 2018
Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS)Luca Gianotti, Marc G Besselink, Marta Sandini, et al.
Journal of Medicinal Chemistry|July 3, 2019
Discovery of a First-in-Class Receptor Interacting Protein 2 (RIP2) Kinase Specific Clinical Candidate, 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethyl Dihydrogen Phosphate, for the Treatment of Inflammatory DiseasesPamela A Haile, Linda N Casillas, Bartholomew J Votta, et al.
Pageof 36